Darae Ko Selected Research

Cardiovascular Diseases (Cardiovascular Disease)

1/2024	Use of Lecanemab for Patients With Cardiovascular Disease: The Challenge of Uncertainty.
12/2023	Fall risk and cardiovascular outcomes of first-line antihypertensive medications in nursing home residents.
1/2023	Frailty and Cardiovascular Mortality: A Narrative Review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Darae Ko Research Topics

Disease

12	Atrial Fibrillation 11/2023 - 05/2014
9	Stroke (Strokes) 01/2024 - 05/2014
4	Frailty 11/2023 - 01/2023
4	Heart Failure 10/2023 - 11/2017
4	Venous Thromboembolism 01/2023 - 09/2014
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 01/2023
3	Myocardial Infarction 11/2022 - 11/2017
2	Heart Diseases (Heart Disease) 01/2024 - 01/2023
2	Diabetes Mellitus 01/2018 - 11/2017
1	Obesity 01/2024
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2024
1	Wounds and Injuries (Trauma) 12/2023
1	Hip Fractures (Intertrochanteric Fractures) 12/2023
1	ST Elevation Myocardial Infarction 11/2023
1	Hemorrhagic Fever with Renal Syndrome (HFRS) 01/2023
1	Myocarditis (Carditis) 11/2021
1	Sepsis (Septicemia) 11/2021
1	Pericarditis 11/2021
1	Pneumonia (Pneumonitis) 11/2021
1	Pneumothorax 11/2021
1	Respiratory Insufficiency (Respiratory Failure) 11/2021
1	Thyrotoxicosis 11/2021
1	Embolic Stroke 01/2021
1	Ischemic Stroke 01/2021
1	Cerebral Hemorrhage 08/2018
1	Insulin Resistance 01/2018
1	Orthostatic Hypotension (Postural Hypotension) 01/2018
1	Hypertension (High Blood Pressure) 01/2018
1	Thromboembolism 04/2017
1	Infarction (Infarctions) 01/2017
1	Inflammation (Inflammations) 01/2015
1	Thrombophilia 01/2015
1	Hemorrhage 09/2014

Drug/Important Bio-Agent (IBA)

6	AnticoagulantsIBA 11/2023 - 05/2014
4	Warfarin (Coumadin)FDA LinkGeneric 11/2023 - 05/2014
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2015
2	CholesterolIBA 01/2024 - 01/2023
2	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 01/2023
2	Antihypertensive Agents (Antihypertensives)IBA 11/2022 - 11/2017
2	Vitamin K FDA Link 08/2018 - 05/2014
1	lecanemabIBA 01/2024
1	omega-Chloroacetophenone (Mace)IBA 12/2023
1	Prasugrel Hydrochloride FDA Link 11/2023
1	Clopidogrel (Plavix)FDA Link 11/2023
1	TicagrelorIBA 11/2023
1	apixabanIBA 11/2023
1	RivaroxabanIBA 11/2023
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 10/2023
1	AngiotensinsIBA 10/2023
1	Neprilysin (Neutral Endopeptidase)IBA 10/2023
1	Mineralocorticoid Receptor AntagonistsIBA 10/2023
1	ReninIBA 10/2023
1	chemotactic factor inactivatorIBA 01/2023
1	EicosanoidsIBA 11/2022
1	danaparoid (Orgaran)FDA Link 01/2021
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2020
1	Liraglutide FDA Link 01/2018
1	hydroxide ionIBA 01/2018
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017

Therapy/Procedure

8	Therapeutics 10/2023 - 09/2014
1	Percutaneous Coronary Intervention 11/2023
1	Precision Medicine 01/2023
1	Length of Stay 01/2023
1	Secondary Prevention 01/2021
1	Anticoagulation Reversal 08/2018